Skip to content

Aggressiveness of Care at the End of Life in Cancer Patients

Aggressiveness of Care at the End of Life in Cancer Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00980122
Enrollment
250
Registered
2009-09-18
Start date
2008-03-31
Completion date
Unknown
Last updated
2010-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Cancer

Keywords

Advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.

Brief summary

Cancer is the commonest cause of death in Singapore, and many cancer deaths occur in hospital. Management of cancer patients is getting more complex with constant development of new drugs, interventional procedures and supportive measures. Despite this, the majority of advanced cancer patients will die from their disease or related complications. There is a lack of data on the utilisation of health resources in advanced cancer patients in this country. In this study the investigators ask themselves how aggressive care was in the last 3 months of the patient's life. The investigators will be collecting data on specific cancer treatments, interventional procedures, and supportive measures.

Interventions

None listed

Sponsors

National University Hospital, Singapore
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Advanced cancer patients who passed away as an inpatient in NUH, under the department of Haematology Oncology.

Exclusion criteria

* Patients with haematologic malignancies.

Design outcomes

Primary

MeasureTime frame
To describe the trends in the aggressiveness of care for advanced cancer patients near the end of life.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026